Astria Therapeutics Inc.
01/27/2026 | Press release | Distributed by Public on 01/28/2026 05:08
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 27, 2026 |
| Accession Number: | 0001140361-26-002206 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Astria Therapeutics Inc. published this content on January 27, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 28, 2026 at 11:08 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]